Eton Pharmaceuticals, Inc.

NasdaqGM:ETON Stock Report

Market Cap: US$324.8m

Eton Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ETON Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Oct 24BuyUS$79,814Opaleye Management Inc.Company10,000US$7.98
08 Oct 24BuyUS$434,137Opaleye Management Inc.Company62,070US$7.22
11 Sep 24BuyUS$237,500Opaleye Management Inc.Company50,000US$4.75
10 Sep 24BuyUS$267,375Opaleye Management Inc.Company57,500US$4.65
26 Apr 24SellUS$5,946,000Harrow, Inc.Company1,982,000US$3.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ETON?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,296,2545.02%
Hedge Funds4,249,73916.4%
Institutions6,191,70724%
General Public14,098,50454.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 43.83% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11%
Opaleye Management Inc.
2,852,070US$35.9m2.59%6.05%
5.41%
EcoR1 Capital, LLC
1,397,669US$17.6m147%0.6%
4.16%
Sean Brynjelsen
1,074,940US$13.5m0%no data
3.98%
The Vanguard Group, Inc.
1,027,688US$12.9m0%no data
3.87%
Nantahala Capital Management, LLC
998,733US$12.6m6.17%0.95%
2.39%
Westside Investment Management, LLC
618,675US$7.8m5.68%1.64%
2.24%
Acuitas Investments, LLC
579,960US$7.3m0%2.17%
1.16%
Paradigm Capital Management, Inc.
300,000US$3.8m0%0.17%
1.1%
BlackRock, Inc.
284,855US$3.6m0.87%no data
1.06%
Geode Capital Management, LLC
272,696US$3.4m13.5%no data
1.01%
Parkman Healthcare Partners LLC
260,226US$3.3m2.78%0.45%
0.98%
Bridgeway Capital Management, LLC
253,362US$3.2m0%0.05%
0.92%
Wasatch Advisors LP
238,565US$3.0m0%0.01%
0.77%
Aristides Capital LLC
200,000US$2.5m0%0.95%
0.5%
EAM Investors, LLC
128,276US$1.6m0%0.23%
0.46%
Susquehanna International Group, LLP, Asset Management Arm
119,347US$1.5m-11.1%no data
0.45%
Thompson, Siegel & Walmsley LLC
115,030US$1.4m-9.94%0.02%
0.41%
Acadian Asset Management LLC
105,954US$1.3m-12.1%no data
0.32%
Renaissance Technologies LLC
83,400US$1.0m-21.7%no data
0.32%
State Street Global Advisors, Inc.
81,403US$1.0m0%no data
0.29%
BNY Asset Management
74,491US$936.4k0%no data
0.26%
Charles Casamento
68,420US$860.0k0%no data
0.25%
Connor, Clark & Lunn Investment Management Ltd.
65,014US$817.2k86.6%no data
0.25%
Northern Trust Global Investments
64,130US$806.1k7.15%no data
0.23%
Paul Maier
59,745US$751.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 06:41
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eton Pharmaceuticals, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew D'SilvaB. Riley Securities, Inc.
Chase KnickerbockerCraig-Hallum Capital Group LLC
Swayampakula RamakanthH.C. Wainwright & Co.